NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CellChorus

CellChorus

Private
Houston, TexasHealthcare & Life Scienceshttps://cellchorus.com/

Last Round

Grant

Aug 25, 2025

Total Funding Raised

$3.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CellChorus is a biotechnology company that has developed a visual artificial intelligence platform for high-throughput, dynamic single-cell analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

single-cell analysistime-lapse imagingTIMINGcell therapydrug discoverylive cell imagingfunctional profilingcontract researchnanowell gridsbiotech toolsAI microscopysingle-cell sequencingSBIRcell behaviordigital pathology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CellChorus Comparables

Compare CellChorus with similar companies based on industry and business-model similarity.

CellChorus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Celldom
86%
Enrich Biosystems
80%
ARRALYZE
76%

CellChorus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 25, 2025
GrantMay 2, 2024
GrantJun 28, 2023
GrantJun 21, 2023
AcceleratorAug 31, 2021

CellChorus Investors

Notable investors and investment history

CellChorus investors
InvestorRounds
National Cancer InstituteGrant
NIH RADxGrant
Y CombinatorAccelerator
BioTools InnovatorGrant
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors grew 259% MoM, from 375 to 1.3K.

  • Aug 25, 2025

    $200K grant from BioTools Innovator VANGUARD.

CellChorus Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CellChorus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CellChorus's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range13
Year Founded2020
Last FundingAug 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.